These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1692 related items for PubMed ID: 16837886

  • 1. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [Abstract] [Full Text] [Related]

  • 2. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H.
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [Abstract] [Full Text] [Related]

  • 3. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
    Brynhildsen J, Hammar M.
    Maturitas; 2005 Apr 11; 50(4):344-52. PubMed ID: 15780536
    [Abstract] [Full Text] [Related]

  • 4. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
    Ylikorkala O, Lim P, Caubel P.
    Clin Ther; 2000 May 11; 22(5):622-36. PubMed ID: 10868559
    [Abstract] [Full Text] [Related]

  • 5. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec 11; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Nickelsen T, Creatsas G, Rechberger T, Depypere H, Erenus M, Quail D, Arndt T, Bonnar J, Euralox 1 Study Group.
    Climacteric; 2001 Dec 11; 4(4):320-31. PubMed ID: 11770189
    [Abstract] [Full Text] [Related]

  • 7. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S, Ylikorkala O, Arrenbrecht S.
    Int J Fertil Womens Med; 1997 Dec 11; 42 Suppl 2():376-87. PubMed ID: 9397385
    [Abstract] [Full Text] [Related]

  • 8. Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.
    Mueck AO, Genazzani AR, Samsioe G, Vukovic-Wysocki I, Seeger H.
    Menopause; 2007 Dec 11; 14(6):978-84. PubMed ID: 17595593
    [Abstract] [Full Text] [Related]

  • 9. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
    Hemelaar M, van der Mooren MJ, Mijatovic V, Bouman AA, Schijf CP, Kroeks MV, Franke HR, Kenemans P.
    Menopause; 2003 Dec 11; 10(6):550-8. PubMed ID: 14627865
    [Abstract] [Full Text] [Related]

  • 10. Intranasal continuous combined 17 beta-estradiol/norethisterone therapy improves the lipid profile in healthy postmenopausal women.
    Hemelaar M, Kenemans P, de Bie L, van de Weijer PH, van der Mooren MJ.
    Fertil Steril; 2006 Apr 11; 85(4):979-88. PubMed ID: 16580384
    [Abstract] [Full Text] [Related]

  • 11. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI, Crook D, Marsh MS, Ellerington MC, Whitehead MI, Stevenson JC.
    Obstet Gynecol; 1994 Aug 11; 84(2):222-6. PubMed ID: 8041534
    [Abstract] [Full Text] [Related]

  • 12. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
    Odmark IS, Bäckström T, Haeger M, Jonsson B, Bixo M.
    Maturitas; 2004 Jun 15; 48(2):137-46. PubMed ID: 15172088
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR, Melo RN, Gebara OC, D'Amico EA, Nussbacher A, Halbe HW, Pinotti JA.
    Climacteric; 2005 Mar 15; 8(1):63-70. PubMed ID: 15804733
    [Abstract] [Full Text] [Related]

  • 16. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M, Fait T, Kovar J, Poledne R, Ceska R.
    Metabolism; 2008 Aug 15; 57(8):1088-92. PubMed ID: 18640386
    [Abstract] [Full Text] [Related]

  • 17. Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.
    Falkeborn M, Lithell H, Persson I, Vessby B, Naessén T.
    Climacteric; 2002 Sep 15; 5(3):240-8. PubMed ID: 12419082
    [Abstract] [Full Text] [Related]

  • 18. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
    Erenus M, Karakoç B, Gürler A.
    Climacteric; 2001 Sep 15; 4(3):228-34. PubMed ID: 11588947
    [Abstract] [Full Text] [Related]

  • 19. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M, Theppisai U, Manonai J, Suchartwatnachai C, Jorgensen LN.
    Acta Obstet Gynecol Scand; 2003 Sep 15; 82(9):857-66. PubMed ID: 12911449
    [Abstract] [Full Text] [Related]

  • 20. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
    Balci H, Altunyurt S, Acar B, Fadiloglu M, Kirkali G, Onvural B.
    Maturitas; 2005 Apr 11; 50(4):289-93. PubMed ID: 15780528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 85.